Adipokines and stroke: A systematic review and meta‐analysis of disease risk and patient outcomes

Thomas A. Agbaedeng,Peter E. Iroga,Vishmi Mayasha Rathnasekara,Anastasia L. Zacharia
DOI: https://doi.org/10.1111/obr.13684
IF: 10.867
2024-02-01
Obesity Reviews
Abstract:Summary Obesity is reported to increase stroke risk, with adipocyte‐derived cytokines or adipokines implicated as mediators. However, the relationship between adipokines and stroke is not well clarified. Thus, we aimed to evaluate the association of adipokines with stroke using fully adjusted risk estimates that incorporated body mass index in a meta‐analysis. Data from 52 studies (62,428 patients) were pooled in a random‐effects meta‐analysis. Adiponectin was independently associated with a lower risk of pre‐existing stroke (adjusted odds ratio: 0.64 [95% confidence interval: 0.46–0.88], p
endocrinology & metabolism
What problem does this paper attempt to address?